press release – Medical Alley Association

press release

FastWave Medical Announces IVL Utility Patent Granted From USPTO to Treat Cardiovascular Calcium

FastWave Medical received an allowance of the patent within just six months of filing, demonstrating the company’s ability to quickly execute in the multi-billion dollar intravascular lithotripsy (IVL) market. MINNEAPOLIS (PRWEB) FEBRUARY 01, 2023 FastWave Medical, a privately held company incubated by partners of Big Sky Biomedical, announced today it has been awarded a utility patent from […]

Velentium and ADV Integrity Announce Sale of Oil & Gas Division

ADV Integrity’s acquisition enables Velentium to focus on medical device design, development, and manufacturing. HOUSTON – Feb. 1, 2023 – Velentium, a professional engineering firm that specializes in the design and manufacturing of therapeutic and diagnostic active medical devices, today announced the sale of its oil & gas division to ADV Integrity, a Texas-based engineering consulting and […]

Medica joins Medical Alley Association as Sustaining Partner 

MEDICAL ALLEY, Minn. (2/1/2023) — Today, Medical Alley Association President & CEO Roberta ‘Bobbie’ Dressen announced Medica, a leading health insurance provider, has joined Medical Alley Association as a Sustaining Partner.    “With a focus on innovation and patient-centered care, Medica has built a reputation for excellence in the healthcare industry,” Dressen said. “We are delighted […]

KOAG Receives FDA Clearance for Vascette® HP
Hemostatic Pad for Vascular Closure

KOAG LLC, a Minneapolis-based medical device firm engaged in the  design of innovative, topical vascular closure systems, announced today it  received FDA clearance for its Vascette® HP device.  Vascette® is a unique, topical closure pad incorporating a proprietary,  plant-derived, surgical hemostatic foam. The Vascette® patent-pending  technology supports rapid hemostasis (blood stoppage) after cardiac  catheterization without […]

MedTrace Receives U.S. Patent for Diagnosing the Human Heart

Today, MedTrace Pharma A/S announce that the U.S. Patent and Trademark Office issued a patent to MedTrace for the company’s method for diagnosing the human heart. The patent protects MedTrace’s unique way of modelling the human heart via PET flow signals. The method, an algorithm, is the foundation of aQuant, the name of the company’s […]

ThermaSolutions​ Announces FDA Approval of HurriChem™

Aerosolizing laparoscopic irrigator is first in U.S. White Bear Lake, MN; January 27, 2023​ — ​ThermaSolutions​ announces immediate availability of the HurriChem™ Device Kit in the United States as a new tool for laparoscopic irrigation, utilizing aerosolization of liquid into the abdomen.  The HurriChem Device Kit contains a stainless-steel wand and braided polyurethane tubing. It […]

In the Know: Healthcare News for January 30, 2023

US FDA Gives Imricor Medical Systems (ASX:IMR) Green Light to Begin VISABL-ALF Trial Cerebral Therapeutics Names Julie Foster as Chief Operating Officer Bio-Techne Launches the MauriceFlex™ System, Adding cIEF Fractionation Capability to the Gold Standard Maurice Assays MOBE to Provide Personalized Health Guidance to Polaris Employees Francis Medical Appoints Andrew Cleeland to Board of Directors […]

Over 25 Researchers, Entrepreneurs and Companies to Join TMC Innovation Accelerator Cohorts

HOUSTON, TX (January 18, 2023) – Texas Medical Center Innovation (TMCi) announced today that eight startups are set to join the Spring 2023 Accelerator for HealthTech cohort, and 21 participants are set to join the 2023 Accelerator for Cancer Therapeutics cohort. TMCi’s accelerator programs bring innovative entrepreneurs and companies from around the world to the TMC Innovation Factory in Houston, connecting […]

Fang Consulting Assists ThermaSolutions to Gain 510(k) Authorization for New Device

Fang Consulting is extremely happy to announce that it has assisted ThermaSolutions in receiving 510(k) authorization for their new HurriChem device. ThermaSolutions developed the HurriChem, a unique aerosolization tool used in abdominal surgery procedures. Our team at Fang Consulting helped organize the 510(k) submission resulting in the HurriChem device receiving authorization with only one request […]

Cerebral Therapeutics Names Julie Foster as Chief Operating Officer

Strategic Appointment to Guide Business Operations, Growth and Portfolio Scalability AURORA, Colo.–(BUSINESS WIRE)–Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment of MedTech industry veteran Julie Foster as Chief Operating Officer. Julie succeeds John Foster who served as Cerebral Therapeutic’s President and COO since 2019, who will move […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER